Search Results 621-630 of 17209 for dialysis

  1. A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 - Mayo Clinic

    Hemodialysis/peritoneal dialysis combination therapy or peritoneal dialysis alone. Diagnosis of conditions other than PH1 contributing to renal ...

  2. Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction - Mayo Clinic

    Peritoneal or hemodialysis within 90 days or anticipation that dialysis or ultrafiltration of any form will be required during the study period; Systolic ...

  3. Dry skin - Symptoms and causes - Mayo Clinic

    Some people develop dry, thick skin after undergoing treatment for cancer, receiving dialysis or taking certain medications. Aging. As people age, the skin ...

  4. Dofetilide (oral route) - Mayo Clinic

    Patients receiving dialysis treatment—Should not be used in patients with these conditions. Kidney disease—Higher blood levels may occur, which may increase ...

  5. Fistula Clinical Trials - Mayo Clinic Research

    Duplex Ultrasonography to Identify Reduced Dialysis Access Blood Flow that May Potentially Threaten Function and Patency of Arteriovenous Fistula or Graft No ...

  6. Deferoxamine (injection route) - Mayo Clinic

    Dialysis treatment or; Encephalopathy (brain disease), aluminum-related—May increase risk for more serious side effects. Anuria (not able to form urine) or ...

  7. COVID-19: Who's at higher risk of serious symptoms? - Mayo Clinic

    Chronic kidney disease. Especially if you are on dialysis. These diseases become more common as people age. But they can affect people of any age ...

  8. Study of Hemodynamic-GUIDEd Management of Heart Failure - Mayo Clinic

    Glomerular Filtration Rate (eGFR) < 25 mL/min and non-responsive to diuretic therapy, or receiving chronic dialysis. Inability to tolerate or receive dual ...

  9. IgA nephropathy (Berger disease) - Doctors and departments - Mayo Clinic

    Intensive care, Dialysis, End-stage renal disease, IgA nephropathy, Glomerular disease, Kidney failure. Research. Through the Mayo Nephrology Collaborative ...

  10. A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease - Mayo Clinic

    Has a pre-existing requirement for renal dialysis. Has undergone percutaneous transluminal renal angioplasty (PTRA) within 12 months before the index EVAR ...